Ihnatowicz et al
Tanguy S, Morel S, Berthonneche C, Toufektsian M-C, de Lorgeril M, Ducros V, et al
Injection Site Reactions: Redness, pain, or swelling at the injection site is possible
Suitability and protocol intensity are determined only after individual clinical evaluation
Key Peptides mechanisms and administration compare as receptor agonists (bremelanotide, melanotan II), neuroendocrine stimulants (kisspeptin, gonadorelin), and growth hormone releasers (tesamorelin, ipamorelin as a related peptide)
These precautions are in place to ensure the safe and effective use of the medication, adhering to regulatory guidelines for its approved uses